Breakthrough 2026: Madrid | February 10-11
Join pharmaceutical leaders, regulators, and innovators in Madrid for two days of actionable strategies, AI advancements, and high-value networking.
Madrid, Spain
10 – 11 Feb 2026
Operationalizing AI: Turning proven AI use cases into everyday practice across life sciences.
Join pharmaceutical leaders, regulators, and innovators in Madrid for two days of actionable strategies, AI advancements, and high-value networking.
Explore how regulatory teams are leveraging GenAI and advanced automation to streamline operations, increase precision, and stay compliant.
Purpose-built to handle this transition, MultiVigilance helps pharmacovigilance and clinical safety teams move forward with confidence, speed, and full compliance.
Alistair Hankin is Industry Principal, Life Sciences at Snowflake, a pioneering data cloud platform that helps organizations mobilize their data for innovation and growth.
Insights from Mariette Boerstoel, SVP, Worldwide Patient Safety Officer, Bristol ...
When any change is made to a product or its ...
At Breakthrough 2025, independent regulatory expert Preeya Beczek moderated the panel debate, Regulatory Operations: Driving Progress and Preparing for the Future.
At Breakthrough in Zurich, Felix Arellano, Global Head of Drug Safety at Roche, shared a candid and inspiring account of Roche’s multi-year journey to launch their next-generation safety system: Voyager.
Our recent webinar “Embracing a Modular Strategy for Accelerated Digital Transformation in Safety Case Intake” featured industry experts discussing how leading organizations are leveraging modular, GenAI-powered solutions to seamlessly future-proof their Safety operations and integrate cutting-edge technologies in months, not years.
Relive the most exciting moments, key insights, and groundbreaking discussions from Breakthrough 2025.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved